Summary

The global Artificial Intelligence Eye Screening System market was valued at US$ 150.94 million in 2025 and is anticipated to reach US$ 1,165.99 million by 2032, at a CAGR of 36.85% from 2026 to 2032.
The North American market for Artificial Intelligence Eye Screening System is projected to increase from US$ 53.94 million in 2025 to US$ 357.13 million by 2032, at a CAGR of 34.24% over 2026–2032.
The Asia-Pacific market for Artificial Intelligence Eye Screening System is projected to rise from US$ 60.96 million in 2025 to US$ 570.08 million by 2032, at a CAGR of 40.06% over 2026–2032.

The global market for Artificial Intelligence Eye Screening System in Medical Institutions is estimated to increase from US$ 105.08 million in 2025 to US$ 786.26 million by 2032, at a CAGR of 36.24% from 2026 to 2032.
Major global companies of Artificial Intelligence Eye Screening System include Airdoc Technology, Digital Diagnostics, Optomed, Eyenuk, RetinaLyze System, VUNO, Sibionics Technology, Medimaging Integrated Solution, Aeye Health, Evolucare Technologies (OphtAI), EyRIS (SELENA+), Vistel and RETINA-AI Health, etc. In 2025, the world’s top three vendors accounted for approximately 42.1% of revenue.
This report delivers a comprehensive overview of the global Artificial Intelligence Eye Screening System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Intelligence Eye Screening System. The Artificial Intelligence Eye Screening System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Artificial Intelligence Eye Screening System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Intelligence Eye Screening System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
 Airdoc Technology
 Digital Diagnostics
 Optomed
 Eyenuk
 RetinaLyze System
 VUNO
 Sibionics Technology
 Medimaging Integrated Solution
 Aeye Health
 Evolucare Technologies (OphtAI)
 EyRIS (SELENA+)
 Vistel
 RETINA-AI Health

Segment by Type
 Diabetic Retinopathy (DR)
 Age-Related Macular Degeneration (AMD)
 Myopia
 Others


Segment by Application
 Medical Institutions
 Great Health Scene

Segment by Region
 North America
 U.S.
 Canada
 Mexico

 Asia-Pacific
 China
 Japan
 South Korea
 Southeast Asia
 India
 Australia & New Zealand

 Europe
 Germany
 France
 U.K.
 Italy
 Nordic Countries
 Russia
 Rest of Europe

 South America
 Brazil

 Middle East & Africa

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Artificial Intelligence Eye Screening System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, South America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Artificial Intelligence Eye Screening System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032 2
1.2.2 Diabetic Retinopathy (DR) 4
1.2.3 Age-Related Macular Degeneration (AMD) 4
1.2.4 Myopia 5
1.2.5 Others 5
1.3 Market by Application 5
1.3.1 Global Artificial Intelligence Eye Screening System Market Growth by Application: 2021 vs 2025 vs 2032 6
1.3.2 Medical Institutions 7
1.3.3 Great Health Scene 8
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 10
2 Global Growth Trends 11
2.1 Global Artificial Intelligence Eye Screening System Market Perspective (2021–2032) 11
2.2 Global Artificial Intelligence Eye Screening System Growth Trends by Region 12
2.2.1 Global Artificial Intelligence Eye Screening System Market Size by Region: 2021 vs 2025 vs 2032 13
2.2.2 Artificial Intelligence Eye Screening System Historic Market Size by Region (2021–2026) 14
2.2.3 Artificial Intelligence Eye Screening System Forecasted Market Size by Region (2027–2032) 15
2.3 Artificial Intelligence Eye Screening System Market Dynamics 16
2.3.1 Artificial Intelligence Eye Screening System Industry Trends 16
2.3.2 Artificial Intelligence Eye Screening System Market Drivers 17
2.3.3 Artificial Intelligence Eye Screening System Market Challenges 18
2.3.4 Artificial Intelligence Eye Screening System Market Restraints 18
3 Competition Landscape by Key Players 19
3.1 Global Top Artificial Intelligence Eye Screening System Players by Revenue 19
3.1.1 Global Top Artificial Intelligence Eye Screening System Players by Revenue (2021–2026) 19
3.1.2 Global Artificial Intelligence Eye Screening System Revenue Market Share by Players (2021–2026) 20
3.2 Global Top Artificial Intelligence Eye Screening System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3) 21
3.3 Global Key Players Ranking by Artificial Intelligence Eye Screening System Revenue 23
3.4 Global Artificial Intelligence Eye Screening System Market Concentration Ratio 24
3.4.1 Global Artificial Intelligence Eye Screening System Market Concentration Ratio (CR5 and HHI) 24
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Eye Screening System Revenue in 2025 25
3.5 Global Key Players of Artificial Intelligence Eye Screening System Head Offices and Founded Time 26
3.6 Mergers and Acquisitions, Expansion Plans 26
4 Artificial Intelligence Eye Screening System Breakdown Data by Type 27
4.1 Global Artificial Intelligence Eye Screening System Historic Market Size by Type (2021–2026) 27
4.2 Global Artificial Intelligence Eye Screening System Forecasted Market Size by Type (2027–2032) 28
5 Artificial Intelligence Eye Screening System Breakdown Data by Application 29
5.1 Global Artificial Intelligence Eye Screening System Historic Market Size by Application (2021–2026) 29
5.2 Global Artificial Intelligence Eye Screening System Forecasted Market Size by Application (2027–2032) 30
6 North America 31
6.1 North America Artificial Intelligence Eye Screening System Market Size (2021–2032) 31
6.2 North America Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032 31
6.3 North America Artificial Intelligence Eye Screening System Market Size by Country (2021–2026) 32
6.4 North America Artificial Intelligence Eye Screening System Market Size by Country (2027–2032) 32
6.5 United States 34
6.6 Canada 35
6.7 Mexico 36
7 Europe 37
7.1 Europe Artificial Intelligence Eye Screening System Market Size (2021–2032) 37
7.2 Europe Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032 37
7.3 Europe Artificial Intelligence Eye Screening System Market Size by Country (2021–2026) 38
7.4 Europe Artificial Intelligence Eye Screening System Market Size by Country (2027–2032) 38
7.5 Germany 40
7.6 France 41
7.7 U.K. 42
7.8 Italy 43
7.9 Russia 44
7.10 Nordic Countries 45
8 Asia-Pacific 46
8.1 Asia-Pacific Artificial Intelligence Eye Screening System Market Size (2021–2032) 46
8.2 Asia-Pacific Artificial Intelligence Eye Screening System Market Growth Rate by Region: 2021 vs 2025 vs 2032 46
8.3 Asia-Pacific Artificial Intelligence Eye Screening System Market Size by Region (2021–2026) 47
8.4 Asia-Pacific Artificial Intelligence Eye Screening System Market Size by Region (2027–2032) 47
8.5 China 49
8.6 Japan 50
8.7 South Korea 51
8.8 Southeast Asia 52
8.9 India 53
8.10 Australia & New Zealand 54
9 South America 55
9.1 South America Artificial Intelligence Eye Screening System Market Size (2021–2032) 55
9.2 South America Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032 55
9.3 South America Artificial Intelligence Eye Screening System Market Size by Country (2021–2026) 56
9.4 South America Artificial Intelligence Eye Screening System Market Size by Country (2027–2032) 56
9.5 Brazil 58
10 Middle East & Africa 59
10.1 Middle East & Africa Artificial Intelligence Eye Screening System Market Size (2021–2032) 59
10.2 Middle East & Africa Artificial Intelligence Eye Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032 59
10.3 Middle East & Africa Artificial Intelligence Eye Screening System Market Size by Country (2021–2026) 60
10.4 Middle East & Africa Artificial Intelligence Eye Screening System Market Size by Country (2027–2032) 60
10.5 Africa 62
10.6 Middle East 63
11 Key Players Profiles 64
11.1 Airdoc Technology 64
11.1.1 Airdoc Technology Company Details 64
11.1.2 Airdoc Technology Business Overview 64
11.1.3 Airdoc Technology Artificial Intelligence Eye Screening System Introduction 65
11.1.4 Airdoc Technology Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 66
11.1.5 Airdoc Technology Recent Development 66
11.2 Digital Diagnostics 67
11.2.1 Digital Diagnostics Company Details 67
11.2.2 Digital Diagnostics Business Overview 67
11.2.3 Digital Diagnostics Artificial Intelligence Eye Screening System Introduction 68
11.2.4 Digital Diagnostics Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 69
11.2.5 Digital Diagnostics Recent Development 69
11.3 Optomed 70
11.3.1 Optomed Company Details 70
11.3.2 Optomed Business Overview 70
11.3.3 Optomed Artificial Intelligence Eye Screening System Introduction 71
11.3.4 Optomed Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 72
11.3.5 Optomed Recent Development 72
11.4 Eyenuk 73
11.4.1 Eyenuk Company Details 73
11.4.2 Eyenuk Business Overview 73
11.4.3 Eyenuk Artificial Intelligence Eye Screening System Introduction 74
11.4.4 Eyenuk Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 74
11.4.5 Eyenuk Recent Development 75
11.5 RetinaLyze System 76
11.5.1 RetinaLyze System Company Details 76
11.5.2 RetinaLyze System Business Overview 76
11.5.3 RetinaLyze System Artificial Intelligence Eye Screening System Introduction 76
11.5.4 RetinaLyze System Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 77
11.5.5 RetinaLyze System Recent Development 78
11.6 VUNO 78
11.6.1 VUNO Company Details 78
11.6.2 VUNO Business Overview 79
11.6.3 VUNO Artificial Intelligence Eye Screening System Introduction 79
11.6.4 VUNO Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 80
11.6.5 VUNO Recent Development 81
11.7 Sibionics Technology 81
11.7.1 Sibionics Technology Company Details 81
11.7.2 Sibionics Technology Business Overview 81
11.7.3 Sibionics Technology Artificial Intelligence Eye Screening System Introduction 82
11.7.4 Sibionics Technology Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 83
11.7.5 Sibionics Technology Recent Development 83
11.8 Medimaging Integrated Solution 84
11.8.1 Medimaging Integrated Solution Company Details 84
11.8.2 Medimaging Integrated Solution Business Overview 84
11.8.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening System Introduction 85
11.8.4 Medimaging Integrated Solution Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 86
11.8.5 Medimaging Integrated Solution Recent Development 87
11.9 Aeye Health 87
11.9.1 Aeye Health Company Details 87
11.9.2 Aeye Health Business Overview 87
11.9.3 Aeye Health Artificial Intelligence Eye Screening System Introduction 88
11.9.4 Aeye Health Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 89
11.9.5 Aeye Health Recent Development 89
11.10 Evolucare Technologies (OphtAI) 90
11.10.1 Evolucare Technologies (OphtAI) Company Details 90
11.10.2 Evolucare Technologies (OphtAI) Business Overview 90
11.10.3 Evolucare Technologies (OphtAI) Artificial Intelligence Eye Screening System Introduction 91
11.10.4 Evolucare Technologies (OphtAI) Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 92
11.10.5 Evolucare Technologies (OphtAI) Recent Development 92
11.11 EyRIS (SELENA+) 93
11.11.1 EyRIS (SELENA+) Company Details 93
11.11.2 EyRIS (SELENA+) Business Overview 93
11.11.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening System Introduction 94
11.11.4 EyRIS (SELENA+) Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 94
11.11.5 EyRIS (SELENA+) Recent Development 95
11.12 Vistel 95
11.12.1 Vistel Company Details 96
11.12.2 Vistel Business Overview 96
11.12.3 Vistel Artificial Intelligence Eye Screening System Introduction 97
11.12.4 Vistel Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 97
11.12.5 Vistel Recent Development 98
11.13 RETINA-AI Health 98
11.13.1 RETINA-AI Health Company Details 99
11.13.2 RETINA-AI Health Business Overview 99
11.13.3 RETINA-AI Health Artificial Intelligence Eye Screening System Introduction 99
11.13.4 RETINA-AI Health Revenue in Artificial Intelligence Eye Screening System Business (2021–2026) 100
12 Analyst's Viewpoints/Conclusions 102
13 Appendix 103
13.1 Research Methodology 103
13.1.1 Methodology/Research Approach 103
13.1.2 Data Source 106
13.2 Author Details 109
13.3 Disclaimer 109